Absorbable Modified Polymer (AMP®)
Patents for AMP® technology have been issued in the United States, Europe and other countries.
Adhesive Hemostatic Polymer (AHP)
Patent for AHP technology for GI application has been issued in the United States, Europe and other countries.
AMP® technology is a proprietary engineering process that modifies plant starch into biocompatible, absorbable hemostatic polysaccharide.
AMP® particles have a molecular structure that rapidly absorbs water from blood, causing a high concentration of platelets, red blood cells and coagulation proteins at the bleeding site which accelerates the physiologic clotting cascade. The interaction of AMP® particles with blood rapidly produces a gelled matrix that adheres to and seals the bleeding tissue. AMP® particles are readily dissolved by irrigation and are degraded by human enzymes.
AMP® particles have been widely used in open surgery and proven to be safe and effective in achieving hemostasis.
AMP® particles have a molecular structure that rapidly absorbs water from blood, causing a high concentration of platelets, red blood cells and coagulation proteins at the bleeding site which accelerates the physiologic clotting cascade. The interaction of AMP® particles with blood rapidly produces a gelled matrix that adheres to and seals the bleeding tissue. AMP® particles are readily dissolved by irrigation and are degraded by human enzymes.
AMP® particles have been widely used in open surgery and proven to be safe and effective in achieving hemostasis.
Patents for AMP® technology have been issued in the United States, Europe and other countries.
Adhesive Hemostatic Polymer (AHP)
AHP particles are hydrophilic and adhesive. They represent a synthetic polymer which also has the characteristic of resisting acids and bases associated in the GI tract. AHP particles form a gelled, adhesive matrix which provides a mechanical barrier to seal and protect the wound site when in contact with blood or GI fluids. The formed adhesive gel matrix adheres to the wound for several hours to several days. AHP particles are non-degradable by human enzymes and will be eliminated out of the gastrointestinal tract with stool.
Patent for AHP technology for GI application has been issued in the United States, Europe and other countries.